Related Experiment Video
Updated: Jul 15, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Epitopes involved in antibody-mediated protection from Ebola virus
J A Wilson1, M Hevey, R Bakken
1Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USA.
Science (New York, N.Y.)
|March 4, 2000
Summary
Researchers developed protective monoclonal antibodies (mAbs) against Ebola glycoprotein, finding one targets a conserved epitope. These antibodies show therapeutic potential in mice, offering hope for new Ebola virus vaccines and treatments.
Area of Science:
- Virology and Immunology
- Infectious Disease Research
Background:
- Ebola virus poses a significant threat to human health.
- Developing effective countermeasures against Ebola virus is a global priority.
Purpose of the Study:
- To generate and evaluate monoclonal antibodies (mAbs) for protection against Ebola virus.
- To identify protective epitopes on the Ebola glycoprotein.
- To assess the therapeutic potential of protective mAbs.
Main Methods:
- Generation of monoclonal antibodies targeting Ebola glycoprotein.
- Epitope mapping to identify unique binding sites.
- In vivo efficacy studies in a mouse model of Ebola virus infection.
Main Results:
- Several protective mAbs were identified, targeting five distinct epitopes.
- One identified epitope is conserved across pathogenic Ebola virus species.
- Therapeutic administration of protective mAbs 2 days post-exposure conferred protection in mice.
Conclusions:
- Monoclonal antibodies targeting specific Ebola glycoprotein epitopes can provide protection.
- The identification of conserved and protective epitopes is crucial for broad-spectrum therapies.
- These findings support the development of novel Ebola virus vaccines and therapeutic strategies.
